FDAnews
www.fdanews.com/articles/197529-quantumdx-nabs-ce-mark-for-covid-19-assay
CE mark

QuantuMDx Nabs CE Mark for COVID-19 Assay

June 9, 2020

QuantuMDx’s COVID-19 real-time reverse transcriptase (rtRT) polymerase chain reaction (PCR) assay has earned CE mark certification.

The assay delivers results in 75 minutes or less, and its  reagents come freeze-dried in a single vial.

Through a manufacturing agreement with Biofortuna, QuantuMDx is currently capable of producing 2 million tests per week.

View today's stories